反応式
[N:1]1[C:10]2[CH:9]=[CH:8][CH:7]=[C:6]([NH2:11])[C:5]=2[CH:4]=[CH:3][CH:2]=1.[CH3:12][C:13]1([CH2:19][C:20](O)=[O:21])[CH2:18][CH2:17][CH2:16][CH2:15][CH2:14]1>>[CH3:12][C:13]1([CH2:19][C:20]([NH:11][C:6]2[CH:7]=[CH:8][CH:9]=[C:10]3[C:5]=2[CH:4]=[CH:3][CH:2]=[N:1]3)=[O:21])[CH2:18][CH2:17][CH2:16][CH2:15][CH2:14]1参加物
3
実験手順
Prepared according to the method of example 18, using 5-quinolinamine (230 mg) and 1-methyl-cyclohexaneacetic acid (250 mg). Purification (SiO2, methanol:dichloromethane 1:9 as eluant) followed by recrystallisation from methanol/ethyl acetate gave the title compound as a colourless solid (80 mg).
後処理
- customPrepared
- customPurification (SiO2, methanol:dichloromethane 1:9 as eluant)
- customfollowed by recrystallisation from methanol/ethyl acetate
出典と根拠
- ORDレコード
- ord-7a1c2afd8ea74b80b3c13d9496684e3a
- 出典データセット
- uspto-grants-2008_08
- 特許番号
- US07408065B2
関連ノート
読み込み中…